|
TI Pharma researcher is awarded 250,000 euros for research on Parkinson's disease
NWO has awarded a Veni subsidy to 143 young researchers who have recently obtained their PhDs. Rob Lane, a researcher on our GPCR project, is one of the winners. He will receive 250,000 euros to develop his ideas and carry out research over a period of three years. Rob Lane won the award for his submission entitled 'Analyzing a new focal point in Parkinson's disease'.
Read more »
|
Research: dosage of morphine for ill newborns still too imprecise
|
Dosage recommendations for newborns being cared for in an intensive care unit will in the future most likely be based on more individual characteristics than just body weight. This is the result of a study conducted by the Dutch Top Institute Pharma which represents Leiden University (Prof M. Danhof) and the Rotterdam Erasmus Medical Centre/Sophia Children’s Hospital (Prof D. Tibboel).
Read more »
|
|
|
|
TI Pharma researcher on Dutch television
|
New consortium for treatment of hypertension
|
TI Pharma has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications like heart and kidney failure, myocardial infarction and stroke.
Read more »
|
|
|
|
Announcement
‘Barriers to Pharmaceutical Innovation'
On 28 April, the TI Pharma Escher project will organize the workshop ‘Barriers to Pharmaceutical Innovation’. A number of international experts will give their view on this topic, including Prof Hans-Georg Eichler (EMA, London), Prof Donald Light (Princeton, US), Prof Dick de Zeeuw (UMCG) Prof Huub Schellekens (UU), Jacob de Vlieg (MSD) and Jackie Hunter (GSK/IMI). This workshop is for invitees only.
The TI Pharma Escher project brings together university and pharmaceutical partners with the aim of energizing pharmaceutical R&D by identifying, evaluating and removing regulatory and methodological barriers to bring efficacious and safe medicines to patients in an efficient and timely fashion. The project focuses on delivering evidence and credibility for regulatory reform and policy recommendations.
|
Workshops & Events
Impression workshop ‘Modeling and simulation approaches’
|
In November TI Pharma and BioLogue/University of Copenhagen organized the workshop 'Modeling and Simulation Approaches'. The workshop took place in Leiden and Copenhagen. Click here for an impression and the workshop report.
|
|
|
|
Education & Training: Industry Day
20 researchers look behind the scenes in industry
|
TI Pharma organized its first Industry Day in Leiden. 20 researchers participated in the event, and got a look behind the scenes at companies like Crucell, Prosensa, Pharming, BioFocus, Flexgen and to-BBB. Jon de Vlieger, who participated in the event, commented: "The industrial day provides an overview of the variety of opportunities a PhD graduate has within the pharmaceutical and biotech industry. It challenges the participants to think about their own careers.” In 2010 a similar program is scheduled for other cities in the Netherlands.
|
|
|
|
Education & Training: Intellectual Property
30 researchers learn to recognize innovations and inventions
Together with the Center for Translational Molecular Medicine (CTMM) and the BioMedical Materials program (BMM), TI Pharma organized an awareness course on Intellectual Property (IP). In two workshops, thirty researchers learned how to identify and manage new inventions in translational complex research environments. Thanks to positive feedback, the course is expected to be scheduled twice in 2010.
|
Subscribe to the Dutch Life Sciences & Health Weekly
|
The website www.lifescienceshealth.com presents daily news on Dutch life science companies and institutes, allowing you to keep up-to-date with the developments in this highly dynamic and innovative sector in the Netherlands. You can also subscribe to receive a weekly e-mail notification of news headlines.
|
|
|
|
|
|
| |
|
|
Index
Committee Veerman recommends continuation of TI Pharma
TI Pharma researcher is awarded 250,000 euros
Research: dosage of morphine for ill newborns still too imprecise
TI Pharma researcher on Dutch Television
New consortium for treatment of hypertension
'Barriers to Pharmaceutical Innovation'
Impression workshop 'Modeling and simulation approaches'
20 researchers look behind the scenes in industry
30 researchers learn to recognize innovations and inventions
Subscribe to the Dutch Life Sciences Weekly |
|
|
|
|
